IL2 and neoplasm: Thus, we used a similar approach to that of anti-TAG-72 huCC49-IL-2, as shown in Figure 4A. In this model, fractionated IGRT had the same effect on tumor growth as huCC49-IL-2 monotherapy, but the combination therapy was significantly more effective and almost doubled the time required for tumor growth inhibition (Figure 4B).